Ethical Compliance
DR. REDDY S LABORATORIES
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
1.9%
Debt
4.3%
Liquidity
4.5%
Revenue
Debt
Liquidity
1.9%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Global Generics | ₹24,545.30 |
| Psai | ₹2,980.10 |
| Others | ₹391.00 |
| Sale of Spent Chemicals | ₹48.90 |
| Scrap Sales | ₹33.80 |
| Miscellaneous Income, Net | ₹12.00 |
| Other Income | ₹351.60 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹542.70 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹542.70 |
| Total: | ₹542.70 |
| Total Revenue: | ₹28,905.40 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹542.70
₹28,905.40
= 1.9%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
